MediPharm Labs (TSXV:LABS)

  • Symbol:TSXV:LABS
  • Ticker 2:OTC:MEDIF
  • Sector:Industrials
  • Industry:Extraction
  • CEO:Patrick McCutcheon
  • Founded:2015

MediPharm Labs (TSXV:LABS) Stock Price

MediPharm Labs (TSXV:LABS) Company Overview

Founded in 2015, MediPharm Labs is a B2B Canadian Licensed Producer extracting purified pharma-grade cannabis oil and concentrates for the development of extracts and other cannabis-derived products.

The company, the first to receive a license from the ACMPR to produce oils (without first having to receive a cultivation license), is considered a sector-leader and is likely to be one of the top performers in 2019, as it operates in the fastest growing segment of the market – cannabis-derived CBD oils and extracts.

MediPharm Labs (TSXV:LABS) Financials

More From MediPharm Labs...

MediPharm Partners With ADREXPharma to Enter German Market
Clean & Green – MediPharm Receives Organic Certification For Cannabis Products
Ganja Down Under – Medipharm Labs Advances Australian Market Leadership
Match Point – KushCo Secures $50m Credit Facility and Strengthens Advisory Board
Meet The Cannabis Extraction Powerhouses – MediPharm Labs & THC Global
Hitting it Out of the Park – Cresco Labs Acquires Gloucester and Lists on Frankfurt Stock Exchange
MediPharm Labs Displays Strong Growth in Q2 Results
MediPharm Labs Q2 Revenue at $31.5 Million – Up 45% From Previous Quarter
Top of the Food Chain – Supreme Cannabis Acquires Truverra Inc
Stay In The Loop – MediPharm Labs Provides Operational Update
Load More Results

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.


Pat McCutcheon
CEO & Chairman of the Board
Prior to founding MediPharm Labs, Pat McCutcheon enjoyed a 15-year career in the pharmaceutical industry in top sales roles, while also successfully launching a wide range of medical products.

Additionally, McCutcheon holds an Honours Bachelor of Science degree in biology from the University of Western Ontario. He previously worked at Jansen Pharmaceuticals (Johnson & Johnson), where he led the Hospital Division for Renal and Mental Health products.
Keith Strachan
President & Director
Keith Strachan co-founded MediPharm Labs in 2015, when he used his consultancy expertise to break the mould and secure the first Health Canada Licence for cannabis oil production without initially being a cultivator.

Strachan is a seasoned entrepreneur, and has continued to apply his leadership to building out MediPharm Labs’ leading-edge facilities, launching operations and growing its workforce. He is also focused on strategically driving business development with the Company’s many supply, contract processing and white label partner LPs.
Chris Hobbs
Chief Financial Officer & Director
Chris Hobbs has acted as Chief Financial Officer for several private and public companies operating in the resource, health sciences, and technology sectors over the past 18 years.

He is also a member of the Chartered Accountants of Ontario, and holds a Bachelor of Business Administration from the Schulich School of Business at York University.